Oleg Nodelman

This profile gathers the share dealings of Oleg Nodelman across 2 companies, led by Nuvation Bio Inc. and Kindred Biosciences, Inc. Between 12 December 2013 and 21 September 2023, the trades on record add up to 37 filings.

On the open market, the record shows 27 purchases worth €23.3M and 2 sales worth €1.8M. Taken together, the purchases exceed the sales by €21.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants. So far in 2023, the count stands at 6 purchases and no sales.

Half of the purchases are above €183k and half below. 6 out of 16 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Looking at 16 purchases old enough to measure, the stock rose over the following 90 days in 38% of cases; the median change was -23.8%. This is a record of the past, not a forecast.

The record was last updated on 22 September 2023 with an open-market purchase (€150k) in Nuvation Bio Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.